NLRC5 methylation has also been reported in association with Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2), a marker of cardiovascular disease risk in individuals with diabetes44. The gene discussed is NLRC5; the disease is cardiovascular disorder.